OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07507903

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
  • Aktiia SA Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07507903
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07507903. Allocation not applicable; no masking; primary purpose other. Start 2026-04-14 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device
Acronym
OBPM_PANDA2026
Condition
Hypertension
Intervention (Device)
Device under test evaluation against references
Lead sponsor
Aktiia SA (class: industry)

Record details

Record id
cardio:ct-nct07507903
Content hash
8d6e03f195147ac5ac8bb1e9ac1e787788194219b1c3a13545d3fd8d78cf12d4